Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT01466868 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
22
Enrollment
OTHER
Sponsor class

Stopped Regarding the comments of the iDSMB, the sponsor decided to stop the inclusions

Conditions

Interventions

Sponsor

Centre Leon Berard

Collaborators